Neochem Bio Solutions Ltd. is a specialty performance chemicals manufacturer with a strong legacy of over four decades. The company develops 350+ customized formulations that cater to diverse industrial applications, making it a key player in India’s growing specialty chemicals space.
The company’s products play a critical role across multiple sectors, including:
- Textile & Garment Washing
- Home & Personal Care (HPC)
- Institutional & Industrial Cleaning
- Water Treatment
- Paints & Coatings
- Paper & Pulp
- Construction Chemicals
- Rubber Processing
- Dyes & Pigments
Neochem offers pre-treatment, dyeing, finishing, printing, and coating auxiliaries for all fabric types, ensuring efficient and high-quality textile processing.
Neochem’s product portfolio spans four key segments—polymers, surfactants, silicones, and esters & bio-based solutions—providing a diversified range of specialty chemicals that support its strong presence across both mature and emerging industrial markets.
Neochem operates a fully integrated manufacturing facility at Saket Industrial Estate, Village Moraiya, Sanand, Ahmedabad.
The facility has an installed capacity of 22,000 MTPA and spans 6,763 sq. meters, featuring water-based specialty chemical manufacturing with controlled reactors, in-process testing, and modern QA/QC systems.
Neochem Bio Solutions IPO – Details
| IPO Opening Date | 02 December 2025 |
| IPO Closing Date | 04 December 2025 |
| Issue Type | Bookbuilding IPO |
| Issue Size | Total Issue: 45,88,800 Shares Worth ₹44.97 Crore Fresh Issue: 45,88,800 Shares Worth ₹44.97 Crore |
| Face Value | ₹10 per equity share |
| IPO Price | ₹93 – ₹98 per share |
| Market Lot | 1200 Shares |
| Min Order | 1200 Shares [ 1 Lot ] |
| Listing At | NSE SME |
| Registrar | MUFG Intime India Pvt.Ltd. |
| QIB Shares Offered | 50% |
| NII Shares Offered | 15% |
| Retail Shares Offered | 35% |
Neochem Bio Solutions IPO – Date Schedule
| IPO Open Date | 02 December 2025 |
| IPO Close Date | 04 December 2025 |
| Basis of Allotment | 05 December 2025 |
| Initiation of Refund | 08 December 2025 |
| Credit of Shares to Demat | 08 December 2025 |
| IPO Listing Date | 09 December 2025 |
| Cut-off time for UPI mandate confirmation | 5 PM on December 04, 2025 |
Neochem Bio Solutions IPO – Lots Size & Price
| Application | Lots | Shares | Amount |
|---|---|---|---|
| Retail (Min) | 2 | 2400 | ₹2,35,200 |
| Retail (Max) | 2 | 2400 | ₹2,35,200 |
| S-HNI (Min) | 3 | 3600 | ₹3,52,800 |
| S-HNI (Max) | 8 | 9600 | ₹9,40,800 |
| B-HNI (Min) | 9 | 10,800 | ₹10,58,400 |
Competitive Strength
- Strengthening the presence across end-user application industries.
- Commitment to continuous development of innovative performance chemistries and sustainable solutions.
- Continued focus on expansion of geographical presence.
- Leverage existing strategic collaborations and partnerships to diversify end-user industries.
Company Promoters
- Swapnil Rameshbhai Makati
- Hemangini Swapnil Dathia
Company Financials
| Period | Total Revenue | Total Expense | Profit After Tax | Total Borrowings |
|---|---|---|---|---|
| 31 March 2023 | ₹48.79 Cr | ₹47.27 Cr | ₹1.07 Cr | ₹26.24 Cr |
| 31 March 2024 | ₹62.01 Cr | ₹59.34 Cr | ₹1.80 Cr | ₹33.32 Cr |
| 31 March 2025 | ₹86.15 Cr | ₹75.89 Cr | ₹7.75 Cr | ₹35.62 Cr |
| 30 September 2025 | ₹47.18 Cr | ₹39.85 Cr | ₹5.48 Cr | ₹38.54 Cr |
Key Performance Indicator
| KPI | Values |
|---|---|
| ROE | 48.82% |
| ROCE | 41.67% |
| Debt\Equity | 1.80 |
| RoNW | 48.82% |
| PAT Margin | 9.00% |
| EBITDA Margin | 15.58% |
| Price to Book Value | 5.80 |
| Market Capitalization | ₹167.78 Cr. |
| Pre IPO | Post IPO | |
|---|---|---|
| EPS (₹) | 6.18 | 6.41 |
| P/E (x) | 15.85 | 15.30 |
Object Of The Issue
| Objects of the Issue | Expected Amount (in Crore) |
|---|---|
| Funding the long-term working capital requirements of the Company. | ₹23.90 |
| Repayment/prepayment, in full or part, of all or certain outstanding borrowings availed by the Company. | ₹10.00 |
| General Corporate Purposes. | – |
✅Strengths
- Diversified specialty chemicals portfolio.
- Presence across multiple industries.
- Strong quality certifications (ISO, ZDHC, GOTS).
- Established manufacturing capacity of 22,000 MTPA.
- 40+ years legacy and industry experience.
⚠️Risks
- High dependence on textile industry.
- No long-term contracts with customers.
- Revenue concentration in top customers.
- Low capacity utilization (22.74%).
- Loss or reduction of major customer orders may impact revenue.
Neochem Bio Solutions IPO Promoter Holding
| Pre Issue Share Holding | 91.12% |
| Post Issue Share Holding | 66.70% |
Neochem Bio Solutions IPO Prospectus
Company Contact Information
| Neochem Bio Solutions Ltd. 303, W1, Opp. Vikramnagar Colony, Off. Iscon- Ambli Road, Ahmedabad, Gujarat, 380058 Phone: +91 079 35217792 Email: compliance@neochem.in Website: http://www.neochem.in/ |
Neochem Bio Solutions IPO Registrar
| MUFG Intime India Pvt.Ltd. Phone: +91-22-4918 6270 Email: neochem.smeipo@in.mpms.mufg.com Website: https://linkintime.co.in/Initial_Offer/public-issues.html |
Neochem Bio Solutions IPO Lead Manager(s)
| 1. Vivro Financial Services Pvt.Ltd. |
Neochem Bio Solutions IPO FAQ
| What is Neochem Bio Solutions IPO? Neochem Bio Solutions IPO is an SME IPO. The issue is priced at ₹93 – ₹98 per equity share. The IPO is to be listed on NSE SME. |
| When Neochem Bio Solutions IPO will open? The IPO is to open on 02 December 2025 for QIB, NII, and Retail Investors. |
| What is Neochem Bio Solutions IPO Investors Portion? The investors’ portion for QIB – 50%, NII – 15%, and Retail – 35%. |
| What is the Neochem Bio Solutions IPO Size? Neochem Bio Solutions IPO size is ₹44.97 Crore. |
| What is Neochem Bio Solutions IPOO Minimum and Maximum Lot Size for Retail? The minimum bid is 2400 Shares with ₹2,35,200 amount, while the maximum bid is 2400 Shares with ₹2,35,200. |
| What is the Neochem Bio Solutions IPO Allotment Date? Neochem Bio Solutions IPO allotment date is 05 December 2025. |
| What is the Neochem Bio Solutions IPO Listing Date? Neochem Bio Solutions IPO listing date is 09 December 2025. The IPO is to be listed on the NSE SME. |
